HIGHLIGHTS
- who: Zheer Kejlberg Al-Mashhadi from the Gu00e4vle Hospital, Sweden Russia Steno Diabetes Center Aarhus, Aarhus University Hospital, Aarhus, Denmark, Department of have published the paper: The risk of major osteoporotic fractures with GLP-1 receptor agonists when compared to DPP-4 inhibitors: A Danish nationwide cohort study, in the Journal: (JOURNAL)
- what: The authors aimed to investigate fracture risk in individuals using GLP-1 RAs versus individuals using DPP-4is. The authors found that the risk of MOF was slightly lower, albeit not significantly, in those treated with GLP1 RA compared to those treated . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.